Trial for Reliability of Urodynamics SysTem

Eligibility Criteria

• 1. Female patient must be ≥ 18 years of age
• 2. Patient is a candidate for urodynamics per standard of care
• 3. Patient or patient's legally authorized representative is able to provide informed consent
• 1. Pregnant (as confirmed by urine pregnancy test or medical history) or breastfeeding, pregnant within the past 6 months or intend to become pregnant during the study period
• 2. Patient has one or more symptoms indicative of a urinary tract infection (UTI) (i.e., fever, costovertebral angle pain or tenderness, suprapubic tenderness, worsening urinary frequency, worsening urgency, and/or dysuria).
• 3. Patient has history of recurrent UTIs (≥ 3 episodes in previous 12 months).
• 4. Patient has used antibiotics within the past 7 days from the baseline/screening visit.
• 5. Patient diagnosed with neurogenic LUTS (which may be associated with one or more of these conditions: normal-pressure hydrocephalus, cerebral palsy, spinal cord injuries, traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, meningomyelocele, spina bifida, dementia, Guillain-Barre syndrome, and tumors involving the central nervous systems or spine).
• 6. Patient diagnosed with interstitial cystitis (IC), bladder pain syndrome, painful bladder syndrome or any etiology of chronic pelvic pain syndrome (CPPS).
• 7. Patient with a urostomy.
• 8. Patient has an atypical anatomic structural variation or has had a previous surgical intervention that has permanently changed structural anatomy anywhere along their lower urinary tract (urethra, pelvic floor, urethral sphincter, and/or bladder wall).
• 9. Patient who has from one or more major strictures in the urethra.
• 10. Patient has a Pelvic Organ Prolapse Quantification (POP-Q) of Grade III or higher (i.e., most distal portion of the prolapse protrudes more than 1 centimeter below the hymen).
• 11. Patient with a colostomy.
• 12. Patient with any abnormal or concerning rectal or vaginal conditions such as ongoing anal fissures, rectocele, fistula, active herpes, active yeast infections, or vaginitis.
• 13. Patient has a known inability to void or is in complete retention.
• 14. Subjects who, at the principal investigator's determination, would not be appropriate for this study